Quarterly report pursuant to Section 13 or 15(d)

Other current assets (Details)

v3.20.2
Other current assets (Details) - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Other current assets    
Corporate tax receivable $ 13,921 $ 19,284
Prepayments 7,754 8,395
Clinical materials 2,488 1,459
Other current assets 2,662 1,809
Total $ 26,825 $ 30,947